171 related articles for article (PubMed ID: 33015740)
41. Pharmacokinetic properties and in silico ADME modeling in drug discovery.
Honório KM; Moda TL; Andricopulo AD
Med Chem; 2013 Mar; 9(2):163-76. PubMed ID: 23016542
[TBL] [Abstract][Full Text] [Related]
42. Impact of Lewis acids on Diels-Alder reaction reactivity: a conceptual density functional theory study.
Xia Y; Yin D; Rong C; Xu Q; Yin D; Liu S
J Phys Chem A; 2008 Oct; 112(40):9970-7. PubMed ID: 18785697
[TBL] [Abstract][Full Text] [Related]
43. Perspective on the Current State-of-the-Art of Quantum Computing for Drug Discovery Applications.
Blunt NS; Camps J; Crawford O; Izsák R; Leontica S; Mirani A; Moylett AE; Scivier SA; Sünderhauf C; Schopf P; Taylor JM; Holzmann N
J Chem Theory Comput; 2022 Dec; 18(12):7001-7023. PubMed ID: 36355616
[TBL] [Abstract][Full Text] [Related]
44. Modeling of activity landscapes for drug discovery.
Bajorath J
Expert Opin Drug Discov; 2012 Jun; 7(6):463-73. PubMed ID: 22475223
[TBL] [Abstract][Full Text] [Related]
45. Solubility prediction, solvate and cocrystal screening as tools for rational crystal engineering.
Loschen C; Klamt A
J Pharm Pharmacol; 2015 Jun; 67(6):803-11. PubMed ID: 25851032
[TBL] [Abstract][Full Text] [Related]
46. Physicochemical descriptors of aromatic character and their use in drug discovery.
Ritchie TJ; Macdonald SJ
J Med Chem; 2014 Sep; 57(17):7206-15. PubMed ID: 24856517
[TBL] [Abstract][Full Text] [Related]
47. The convergence of artificial intelligence and chemistry for improved drug discovery.
Green CP; Engkvist O; Pairaudeau G
Future Med Chem; 2018 Nov; 10(22):2573-2576. PubMed ID: 30499699
[No Abstract] [Full Text] [Related]
48. Successful generation of structural information for fragment-based drug discovery.
Öster L; Tapani S; Xue Y; Käck H
Drug Discov Today; 2015 Sep; 20(9):1104-11. PubMed ID: 25931264
[TBL] [Abstract][Full Text] [Related]
49. Classical simulation of quantum energy flow in biomolecules.
Stock G
Phys Rev Lett; 2009 Mar; 102(11):118301. PubMed ID: 19392249
[TBL] [Abstract][Full Text] [Related]
50. An automated system for determining drug solubility based on laser monitoring technique.
Jouyban-Gharamaleki V; Jouyban-Gharamaleki K; Shayanfar A; Khoubnasabjafari M; Jouyban A
J Lab Autom; 2015 Feb; 20(1):3-9. PubMed ID: 25331492
[TBL] [Abstract][Full Text] [Related]
51. Electrophilicity index revisited.
Pal R; Chattaraj PK
J Comput Chem; 2023 Jan; 44(3):278-297. PubMed ID: 35546516
[TBL] [Abstract][Full Text] [Related]
52. Covalent inhibitors in drug discovery: from accidental discoveries to avoided liabilities and designed therapies.
Bauer RA
Drug Discov Today; 2015 Sep; 20(9):1061-73. PubMed ID: 26002380
[TBL] [Abstract][Full Text] [Related]
53. High-throughput logPo/w determination from UHPLC measurements: Revisiting the chromatographic hydrophobicity index.
Subirats X; Rosés M; Bosch E
J Pharm Biomed Anal; 2016 Aug; 127():26-31. PubMed ID: 26732880
[TBL] [Abstract][Full Text] [Related]
54. Backtranslating clinical knowledge for use in cheminformatics--what is the potential?
Scheiber J
Bioorg Med Chem; 2012 Sep; 20(18):5461-3. PubMed ID: 22626549
[TBL] [Abstract][Full Text] [Related]
55. Can biochemistry drive drug discovery beyond simple potency measurements?
Chène P
Drug Discov Today; 2012 Apr; 17(7-8):388-95. PubMed ID: 22326379
[TBL] [Abstract][Full Text] [Related]
56. Physicochemical characterisation in drug discovery.
Balogh GT
Drug Discov Today Technol; 2018 Jul; 27():1-2. PubMed ID: 30103858
[No Abstract] [Full Text] [Related]
57. A Comparison of Quantum and Molecular Mechanical Methods to Estimate Strain Energy in Druglike Fragments.
Sellers BD; James NC; Gobbi A
J Chem Inf Model; 2017 Jun; 57(6):1265-1275. PubMed ID: 28485585
[TBL] [Abstract][Full Text] [Related]
58. Biophysics: for HTS hit validation, chemical lead optimization, and beyond.
Genick CC; Wright SK
Expert Opin Drug Discov; 2017 Sep; 12(9):897-907. PubMed ID: 28658992
[TBL] [Abstract][Full Text] [Related]
59. Present drug-likeness filters in medicinal chemistry during the hit and lead optimization process: how far can they be simplified?
Mignani S; Rodrigues J; Tomas H; Jalal R; Singh PP; Majoral JP; Vishwakarma RA
Drug Discov Today; 2018 Mar; 23(3):605-615. PubMed ID: 29330127
[TBL] [Abstract][Full Text] [Related]
60. The Most Common Functional Groups in Bioactive Molecules and How Their Popularity Has Evolved over Time.
Ertl P; Altmann E; McKenna JM
J Med Chem; 2020 Aug; 63(15):8408-8418. PubMed ID: 32663408
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
